News & Media

Featured In

In the Press

“It’s likely that it will become endemic because people carry it without knowing or showing symptoms, and some people have diminished immunity that will continue to make them susceptible even post-vaccination,” said Gerald Commissiong, CEO of Todos Medical, Ltd., a COVID-19 screening and testing company."  Click to Read More

Christopher Curley
June 3, 2021

"We do not see significant cause for concern because avian flu viruses are significantly less virulent than coronaviruses and have a more difficult time spreading from person to person." Click to Read More

Gerald Commissiong
June 2, 2021

"Manhattan-based Todos Medical mainly develops cancer-detection tests. But next month it will launch what it believes to be the city’s first mobile Covid-testing labs." Click to Read More

Anne Kadet
March 16, 2021

"Tollovir is being trialled on people by the company Todos Medical in Israel. Todos Medical said past research had shown the drug could work against coronaviruses in general and that it had potential to 'significantly reduce' the severity of Covid." Click to read more

Levi Parsons
May 17, 2021

"The question we've got to ask ourselves is: is this something we can stop or is it inevitable?" said Gerald Commissiong, CEO of Todos Medical, Ltd., a diagnostics company focused on COVID-19 testing, screening and immune support." Click to Read More

Leandra Bernstein
June 10, 2021

"Todos is spearheading research on NLC-001, a proprietary blend of plant extracts that consumers would take in a pill form – like a much stronger vitamin that should be treated as a drug. The FDA granted a certificate of free sale, showing that it is safe to consume."  Click to Read More

Carl Thiese
September 19, 2020

"CEO Gerald Commissiong envisions the company’s 20-foot container boxes parked outside Madison Square Garden serving fans who need a fast lab result to attend a Knicks game. The company has so far spent $1.2 million constructing two portable lab facilities and has 10 more in production." Click to Read More

Anne Kadet
March 16, 2021

"A PILL to kill third wave: Boris Johnson launches 'ambitious' new 'antivirals taskforce' so Britons can take tablets for Covid at home 'by autumn'..."  Click here to read more

Sam Blanchard
April 20, 2021

"We must now marry the information we have learned over the last 6-8 months about COVID-19 with concrete actionable plans that address the bottlenecks required to make people feel safe."  Click to Read More

Gerald Commissiong, CEO of Todos Medical
July 9, 2020

"By focusing on vaccinating as much of the population as possible, public health officials hope to get a baseline immunity to protect against emerging variants of concern. But it's a race against the emergence of variants in other parts of the world where vaccines are unavailable." Click to Read More

Leandra Bernstein
June 10, 2021

"Mr. Commissiong says [mobile testing] units can process 3,000 to 5,000 tests a day, charging $200 a pop. “We think there is going to be big demand in Manhattan with Broadway opening up,” he says." Click to Read More

Anne Kadet
March 16, 2021

“Combined with the likelihood of waning immunity and emerging variants, we should expect that COVID-19 is a virus that will be with us for the long haul,” Commissiong told Healthline.  Click to Read More

Christopher Curley
June 3, 2021

"There will be risks with every plan, however a plan that systematically reduces risks in a stepwise fashion and isolates those risks so the Virus can be contained is what must emerge."  Click to Read More

Gerald Commissiong, CEO of Todos Medical
July 9, 2020

"At the end of the day, there's no denying the biological risk that some of these variants will overcome the vaccines," Commissiong noted. "If we don't help the world get vaccinated ... it's inevitable there's going to be a variant that makes all these vaccines useless." Click to Read More

Leandra Bernstein
June 10, 2021

Stay informed of our latest breakthroughs.